Indefinite Delivery Contract 75H70520D00007
Award Date
3/27/20
Last Date to Order
3/26/21
Federal Agency
Indian Health Service
Awardee
Cepheid
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services Indian Health Service awarded a single-award, indefinite delivery contract to Cepheid to provide COVID-19 reagents, kits, and laboratory supplies. A $668,056 firm fixed price delivery order was issued against this contract to support the agency's testing efforts through the procurement of Cepheid materials. The delivery order aims to bolster coronavirus diagnostic capabilities at IHS sites through October 2021 by furnishing reagents, kits and...
The Department of Health and Human Services Indian Health Service (IHS) awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, a $6,000,000 single-award Indefinite Delivery Contract (IDC) to provide Cepheid supplies for patient care testing. Under this IDC, IHS has issued two firm fixed-price delivery orders to Cepheid. The first is a one-year, $100,074 order for PCR testing supplies to the Cass Lake Hospital, with a maximum period of performance through August 31, 2027....
The Department of Health and Human Services Indian Health Service awarded an indefinite delivery contract to Cepheid, a subsidiary of Danaher Corporation, to provide reagents, laboratory supplies, and equipment in support of COVID-19 testing and the Phoenix Area Indian Health Service's pandemic response efforts. The potential value of the contract is $2,910,647. Four firm fixed price delivery orders totaling $501,800 were issued against the contract to date for supplies to be delivered to...
The Indian Health Service awarded an Agency-Wide Indefinite Delivery/Indefinite Quantity contract to Cepheid to provide laboratory analyzers, testing kits, reagents, and associated support for COVID-19 testing across 177 IHS facilities nationwide. The IDIQ and subsequent delivery orders have a potential value of $128.4 million and contemplate a 12-month base period and four 1-year options. Cepheid will deliver its GeneXpert molecular diagnostic platform along with FDA Emergency Use Authorized...
The Department of Health and Human Services Indian Health Service (IHS) awarded an indefinite delivery/indefinite quantity (IDIQ) contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The IDIQ contract, valued at $30,196,102.90, will provide the IHS with molecular laboratory analytical testing reagents, COVID-19 testing kits, and associated maintenance and support services for healthcare clinics and laboratories serving Native American communities in the Portland,...
The Department of Health and Human Services Indian Health Service (HHS IHS) has awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, multiple firm fixed price Blanket Purchase Agreement (BPA) call contracts to provide laboratory testing supplies, reagents, and equipment. These awards, with potential values ranging from $100,000 to over $1.2 million, support the clinical diagnostic programs of the Indian Health Service through the delivery of Cepheid's molecular testing...
The Department of Health and Human Services Indian Health Service awarded a single-award, indefinite delivery contract to Biofire Diagnostics, LLC on September 1, 2020. With a potential value of $550,060, this contract aims to procure BioFire panels and kits to support COVID-19 testing efforts through August 31, 2021. A subsequent firm fixed price delivery order against the contract was awarded on September 2, 2020 to Biofire Diagnostics, LLC for $279,700. The delivery order is for BioFire...
The federal contract IDV award is a single-award indefinite delivery contract issued by the Indian Health Service (IHS), a component of the U.S. Department of Health and Human Services. The contract, valued at a ceiling of $398,500, was awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide annual service agreements, routine lab supplies, and COVID-19 testing supplies. Under this IDV, Cepheid has received several delivery orders to date. These include a...
The federal contract IDV awarded to Cepheid by the Department of Health and Human Services' Indian Health Service (HHS IHS) provides for the procurement of molecular diagnostic testing equipment, reagents, consumables, and associated maintenance and support services. Cepheid, a for-profit manufacturer of molecular diagnostic solutions, has been awarded multiple delivery orders under this single-award indefinite delivery contract with a total ceiling value of $2,160,000. The delivery orders,...
This Blanket Purchase Agreement (BPA) was awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $1,000,000.00, is for the delivery of TESTING KITS FOR OCAO with a total period of performance through March 29, 2026. The contract does not have a set-aside designation. Under this BPA, IHS has placed two firm fixed-price task orders with Cepheid. The first order, valued at $178,840.00, is for...